Results
|
|
1.
|
Reactions to START:REACTS. MedStar authors:
Year: 2022
Citation: - Lancet. 400(10363):1583, 2022 11 05.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Abboud JA, Amini MH, Familiari F, Murthi AM, Srikumaran U, Verma NN
|
|
|
2.
|
Pertuzumab for the treatment of breast cancer. [Review] MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2014
Citation: - Cancer Investigation. 32(8):430-8, 2014 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
- Review
|
|
|
3.
|
Characterisation of infection-induced SARS-CoV-2 seroprevalence amongst children and adolescents in North Carolina. MedStar authors:
Year: 2023
Citation: - Epidemiology & Infection. 151:e63, 2023 Apr 03.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Ahmed A, Buahin A, Castri P, Dantuluri KL, DeWitt ME, Gibbs M, LaGarde WH, Rossman W, Santos RP, Uschner D, Weintraub WS
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study. MedStar authors:
Year: 2013
Citation: - Oncologist. 18(3):257-64, 2013.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Amadori D, Baselga J, Benyunes MC, Clark E, Cortes J, Ewer MS, Knott A, Miles D, Ross G, Swain SM
|
|
|
9.
|
Presence of anti-viral and anti-parasitic antibodies and cardiovascular mortality: insights from NHANES III. MedStar authors:
Year: 2013
Citation: - International Journal of Cardiology. 168(5):4826-30, 2013 Oct 12.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/General Internal Medicine
Medline publication type:
All authors: - Arora S, Badheka AO, Bhalara V, Chothani A, Cohen MG, Deshmukh A, Grover PM, Khalpada D, Mehta K, Mohamad T, Panaich SP, Parmar NG, Patel N, Patel NJ, Rathod A, Savani GT, Shah N, Singh V
|
|
|
10.
|
Predictive value of autoantibody testing for validating self-reported diagnoses of rheumatoid arthritis in the Women's Health Initiative. MedStar authors:
Year: 2013
Citation: - American Journal of Epidemiology. 177(9):887-93, 2013 May 1.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Chang YF, Deane KD, Holers VM, Kuller L, Mackey R, Moreland L, Robinson W, Walitt B
|
|
|
11.
|
|
|
|
12.
|
Characterization of B-cell receptor clonality and immunoglobulin gene usage at multiple time points during active SARS-CoV-2 infection. MedStar authors:
- Haas, Christopher
- Henry, Kiersten
Year: 2023
Citation: - Journal of Medical Virology. 95(10):e29179, 2023 10.
Institution:
- MedStar Montgomery Medical Center
- MedStar Union Memorial Hospital
Medline publication type:
- Journal Article
- Research Support, N.I.H., Intramural
All authors: - Arons E, Henry K, Haas C, Gould M, Tsintolas J, Mauter J, Zhou H, Burbelo PD, Cohen JI, Kreitman RJ
|
|
|
13.
|
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score >= 50. MedStar authors:
Year: 2021
Citation: - Journal of Clinical Oncology. 39(21):2339-2349, 2021 07 20.
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
All authors: - Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, Jensen E, Leal TA, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riess JW, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Zhao B
|
|
|
14.
|
Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel. MedStar authors:
Year: 2013
Citation: - Anti-Cancer Drugs. 24(10):1084-92, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Brewster M, Cortes J, Garg A, Grincuka E, Hauschild M, Kudaba I, Lum BL, Marier JF, Masuda N, McNally V, Nijem I, Patel T, Ross G, Swain SM, Trinh MM, Visich J
|
|
|
15.
|
|
|
|
16.
|
Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus. MedStar authors:
Year: 2014
Citation: - Journal of Rheumatology. 41(2):300-9, 2014 Feb.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Randomized Controlled Trial
All authors: - Chatham WW, Freimuth WW, Furie RA, Ginzler EM, LBSL02/99 Study Group, McCune WJ, McKay JD, Merrill JT, Petri MA, Stohl W, Wallace DJ, Weinstein A, Zhong ZJ
|
|
|
17.
|
|
|
|
18.
|
Vaccination Serology Status and Cardiovascular Mortality: Insight from NHANES III and Continuous NHANES. MedStar authors:
Year: 2015
Citation: - Postgraduate Medicine. 127(6):561-4, 2015 Aug.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/General Internal Medicine
Medline publication type:
- Journal Article
- Observational Study
All authors: - Arora S, Badheka AO, Bhatt P, Chothani A, Cohen MG, Deshmukh A, Forrest JK, Grines C, Panaich SS, Patel A, Patel N, Patel NJ, Savani C, Shah N, Singh V, Thakkar B
|
|
|
19.
|
|
|
|
20.
|
Pertuzumab: increasing the options. MedStar authors:
- Nunes, Raquel
- Swain, Sandra M
Citation: - Oncology (Williston Park). 28(3):199, 204, 210, 2014 Mar.
Institution: - Washington Cancer Institute
Medline publication type:
- Comment
- Journal Article
- Research Support, Non-U.S. Gov't
|
|
|
21.
|
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naive chronic lymphocytic leukemia: a phase 2 study. MedStar authors:
Year: 2021
Citation: - Leukemia & Lymphoma. 62(8):1816-1827, 2021 08.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Ahn IE, Desai S, Drinkwater DC, Farooqui MZ, Gaglione EM, Herman SEM, Hughes TE, Lindorfer MA, Lotter J, Maric I, Marti GE, Mo C, Nichols C, Nierman P, Pleyer C, Soto S, Stetler-Stevenson M, Sun C, Superata J, Taylor RP, Tian X, Valdez J, Wake L, Wiestner A, Yuan CM
|
|
|
22.
|
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors:
Year: 2013
Citation: - Annals of Oncology. 24(10):2630-5, 2013 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM
|
|
|
23.
|
|
|
|
24.
|
Reply to a. Avan et Al. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Oncology. 33(15):1712, 2015 May 20.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baselga J, Clark E, Kiermaier A, Swain S
|
|
|
25.
|
|
|
|
26.
|
Safety and Efficacy of First-Line Pembrolizumab in Black Patients with Metastatic Non-Small Cell Lung Cancer. MedStar authors:
- Chen, Kevin
- Kim, Chul
- Peravali, Monica
- Rao, Suman
- Veytsman, Irina
Year: 2021
Citation: - Oncologist. 26(8):694-700, 2021 08.
Institution:
- MedStar Franklin Square Medical Center
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department: - Hematology/Oncology Fellowship
Medline publication type:
All authors: - Ahn J, Chen K, Kim C, Liu SV, Peravali M, Rao S, Veytsman I
|
|
|
27.
|
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. MedStar authors:
Year: 2015
Citation: - New England Journal of Medicine. 372(8):724-34, 2015 Feb 19.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, CLEOPATRA Study Group, Cortes J, Ferrero JM, Heeson S, Kim SB, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
28.
|
|
|
|
29.
|
Treatment of HER2-positive metastatic breast cancer. MedStar authors:
Year: 2015
Citation: - New England Journal of Medicine. 372(20):1964-5, 2015 May 14.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baselga J, Clark E, Swain SM
|
|
|
30.
|
|
|
|
31.
|
Anti-PD-L1 Treatment Induced Central Diabetes Insipidus. MedStar authors:
Year: 2018
Citation: - Journal of Clinical Endocrinology & Metabolism. 103(2):365-369, 2018 02 01.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Internal Medcine
Medline publication type:
All authors: - Brownell I, Del Rivero J, Ebenuwa I, Gulley J, Kommalapati A, Strauss J, Tella SH, Zhao C
|
|
|
32.
|
|
|
|
33.
|
Avastin withdrawal symptoms. MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Citation: - Expert Opinion on Pharmacotherapy. 13(3):293-8, 2012 Feb.
Institution: - Washington Cancer Institute
Medline publication type:
- Editorial
- Research Support, Non-U.S. Gov't
|
|
|
34.
|
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. MedStar authors:
Year: 2017
Citation: - Lancet Oncology. 18(11):1493-1501, 2017 Nov
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Attia S, Baker LH, Bolejack V, Burgess M, Butterfield LH, Crowley J, D'Angelo S, Davis LE, Hu J, Lazar AJ, Maki RG, Movva S, Okuno SH, Patel S, Priebat DA, Reed DR, Reinke D, Riedel RF, Rodriguez-Canales J, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wistuba II
|
|
|
35.
|
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Cunningham, A
- Gallagher, Christopher
- Hofmeyer, Mark
- Srichai, M B
- Swain, Sandra M
Year: 2019
Citation: - Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun.
Institution:
- MedStar Health
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Asch FM, Barac A, Cunningham A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Lynce F, Nunes R, Pohlmann PR, Shajahan-Haq A, Smith KL, Srichai MB, Swain SM, Tan MT, Timothee P, Warren R, Yu AF
|
|
|
36.
|
|
|
|
37.
|
|
|
|
38.
|
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. MedStar authors:
Citation: - Lancet Oncology. 14(9):901-8, 2013 Aug.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Blay JY, Chawla S, Choy E, Ferrari S, Grimer R, Henshaw R, Jacobs I, Kroep J, Qian Y, Reichardt P, Rutkowski P, Schuetze S, Seeger L, Skubitz K, Staddon A, Thomas D
|
|
|
39.
|
|
|
|
40.
|
High Hepatitis C Infection Rate Among Baby Boomers in an Urban Primary Care Clinic: Results from the HepTLC Initiative. MedStar authors:
- Ayodele, Adebisi A
- Cha, Hyun A
- Cole, Carmella A
- Daly, Allison P
- Fishbein, Dawn
- Fleming, Ike C
- Geboy, Alexander G
- Mahajan, Sandeep
- Perez, Idene E
- Sewell, Candice F
Year: 2016
Citation: - Public Health Reports. 131 Suppl 2:49-56, 2016 May-Jun
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department:
- Medicine
- Medicine/Gastroenterology
- Medicine/General Internal Medicine
- Medicine/Infectious Diseases
- Nursing
Medline publication type:
All authors: - Ayodele AA, Cha HA, Cole CA, Daly AP, Fishbein DA, Fleming IC, Geboy AG, Mahajan S, Perez IE, Sewell CF
|
|
|
41.
|
|
|
|
42.
|
Efficacy and Safety of Daratumumab-based Regimens in Pretreated Light Chain (AL) Amyloidosis: A Systematic Review. [Review] MedStar authors:
Year: 2022
Citation: - Clinical lymphoma, myeloma & leukemia. 22(5):e285-e292, 2022 05.
Department: - MedStar Health Baltimore Residents
Medline publication type:
All authors: - Ansar I, Ehsan A, Ehsan H, Hashmi H, Masood A, Neupane K, Rafae A, Sana MK, Umar A, Wahab A
|
|
|
43.
|
Risk of cardiovascular adverse events from trastuzumab (Herceptin()) in elderly persons with breast cancer: a population-based study. MedStar authors:
Year: 2014
Citation: - Breast Cancer Research & Treatment. 144(1):163-70, 2014 Feb.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
All authors: - Barac A, Freedman AN, Fu AZ, Huang CY, Isaacs C, Potosky AL, Tsai HT, Warren JL
|
|
|
44.
|
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(33):3744-52, 2014 Nov 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Colon-Otero G, Davidson NE, Geyer CE Jr, Gralow J, Jeong JH, Mamounas E, Martino S, Perez EA, Rastogi P, Romond EH, Sledge G, Suman VJ, Swain SM, Winer EP, Wolmark N, Zujewski JA
|
|
|
45.
|
Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab. MedStar authors:
- Alhaj-Moustafa, Muhamad
- Fitzpatrick, Kelly
- Pilla, Ravi
- Vakiti, Anusha
Year: 2019
Citation: - Journal of Oncology Pharmacy Practice. 25(4):1011-1015, 2019 Jun.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department: - Medicine/General Internal Medicine
Medline publication type:
All authors: - Alhaj-Moustafa M, Fitzpatrick KW, Pilla R, Singh D, Vakiti A
|
|
|
46.
|
Bevacizumab added to neoadjuvant chemotherapy for breast cancer. MedStar authors:
Year: 2012
Citation: - New England Journal of Medicine. 366(4):310-20, 2012 Jan 26.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
All authors: - Adams PT, Atkins JN, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Mamounas EP, Margolese RG, Mehta RS, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
|
|
|
47.
|
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study. MedStar authors:
Year: 2022
Citation: - Journal of Clinical Oncology. 40(5):438-448, 2022 02 10.
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Barrios C, Bonnefoi H, Boulet T, De Laurentiis M, Ellis PA, Fehrenbacher L, Gianni L, Gralow J, Harbeck N, Huang CS, Im SA, Im YH, Ito Y, Krop IE, Liu H, Macharia H, Nowecki Z, Shah J, Song C, Swain SM, Toi M, Trask P, Winer EP
|
|
|
48.
|
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial. MedStar authors:
Year: 2017
Citation: - Lancet Oncology. 18(12):1600-1609, 2017 Dec
Institution: - MedStar Franklin Square Hospital
Medline publication type:
All authors: - Brahmer JR, Csoszi T, Cuffe S, Deitz AC, Fulop A, Gottfried M, Hotta K, Hui R, Lubiniecki GM, O'Brien M, Peled N, Rangwala R, Rao S, Reck M, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Zhang J
|
|
|
49.
|
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). MedStar authors:
Year: 2013
Citation: - Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Amadori D, Baselga J, Clark E, Knott A, Miles D, Ross G, Semiglazov V, Sunpaweravong P, Swain SM
|
|
|
50.
|
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA. MedStar authors:
Year: 2014
Citation: - Annals of Oncology. 25(6):1116-21, 2014 Jun.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Cortes J, Im YH, Lee LF, Miles D, Quah C, Swain SM
|
|
|
51.
|
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. MedStar authors:
Year: 2016
Citation: - Breast Cancer Research & Treatment. 155(2):235-51, 2016 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Amiri-Kordestani L, Chavez KJ, Conway CM, Dine JL, Greer YE, Hewitt SM, Lipkowitz S, Merchant AS, O'Sullivan CC, Sinclair S, Steinberg SM, Stone B, Swain SM, Voeller D
|
|
|
52.
|
|
|
|
53.
|
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Lynce, Filipa
- Swain, Sandra M
Year: 2017
Citation: - Oncologist. 22(5):518-525, 2017 May
Institution:
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
|
|
|
54.
|
|
|
|
55.
|
Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system. MedStar authors:
- Basch, Peter
- Desale, Sameer
- Fernandez, Stephen J
- Fishbein, Dawn A
- Geboy, Alexander G
- Nichols, Whitney L
Year: 2019
Citation: - PLoS ONE [Electronic Resource]. 14(5):e0216459, 2019.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- MedStar Institute for Quality and Safety
- MedStar Washington Hospital Center
Department: - Medicine/Infectious Diseases
Medline publication type:
All authors: - Basch P, Desale S, Fernandez SJ, Fishbein DA, Geboy AG, Nichols WL
|
|
|
56.
|
The presentation, etiologies, pathophysiology, and treatment of pulmonary renal syndrome: A review of the literature. [Review] MedStar authors:
Year: 2022
Citation: - Disease-A-Month. 68(12):101465, 2022 Dec.
Department:
- Internal Medicine & Pediatrics Residency
- MedStar Georgetown University Hospital/MedStar Washington Hospital Center
Medline publication type:
All authors: - Cunningham M, Deleveaux S, Lerma E, Madariaga H, Martin K, Ramaswamy K, Thomas B
|
|
|
57.
|
The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. MedStar authors:
Year: 2014
Citation: - BMC Cancer. 14:307, 2014.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Beattie M, Hurvitz S, Jahanzeb M, Kaufman PA, Lai C, Masaquel A, Mason G, O'Shaughnessy J, Rugo HS, Swain S, Tripathy D, Yoo B
|
|
|
58.
|
Statistical genetic analysis of serological measures of common, chronic infections in Alaska Native participants in the GOCADAN study. MedStar authors:
- Howard, Barbara V
- Zhu, Jianhui
Year: 2013
Citation: - Genetic Epidemiology. 37(7):751-7, 2013 Nov.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Cole SA, Comuzzie AG, Davidson M, Ebbesson SO, Goring HH, Howard BV, Laston S, Maccluer JW, Rubicz R, Umans JG, Voruganti VS, Zhu J
|
|
|
59.
|
|
|
|
60.
|
Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitis. MedStar authors:
- Acharya, Indira
- Smith, Lanaya Williams
- Weisman, David S
Year: 2023
Citation: - BMJ Case Reports. 16(7), 2023 Jul 10.
Institution: - MedStar Union Memorial Hospital
Department:
- Internal Medicine
- Internal Medicine Residency
Medline publication type:
- Case Reports
- Journal Article
All authors: - Acharya I, Arend LJ, Smith LW, Weisman DS
|
|
|
61.
|
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater. MedStar authors:
Year: 2019
Citation: - Journal of Clinical Oncology. 37(7):537-546, 2019 03 01.
Institution: - Medstar Franklin Square Medical Center
Medline publication type:
All authors: - Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riccio A, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Vandormael K, Yang J
|
|
|
62.
|
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. [Review] MedStar authors:
Year: 2014
Citation: - Lancet. 384(9938):164-72, 2014 Jul 12.
Medline publication type:
- Journal Article
- Meta-Analysis
- Research Support, U.S. Gov't, P.H.S.
- Review
All authors: - Baselga J, Bergh J, Blohmer J, Blumenthal G, Bogaerts J, Bonnefoi H, Cameron D, Cortazar P, Costantino JP, Ditsch N, Eidtmann H, Eiermann W, Fasching PA, Gerber B, Geyer CE Jr, Gianni L, Justice R, Loibl S, Mamounas EP, Mehta K, Paik S, Pazdur R, Perou C, Piccart M, Prowell T, Rastogi P, Semiglazov V, Slaets L, Sridhara R, Swain SM, Tang S, Untch M, Valagussa P, von Minckwitz G, Wickerham DL, Wolmark N, Zhang L
|
|
|
63.
|
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM
|
|
|
64.
|
Rheumatoid arthritis in the Women's Health Initiative: methods and baseline evaluation. MedStar authors:
Year: 2014
Citation: - American Journal of Epidemiology. 179(7):917-26, 2014 Apr 1.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Chang Y, Deane KD, Holers VM, Kuller LH, Mackey RH, Moreland LW, Robinson WH, Sokolove J, Walitt BT
|
|
|
65.
|
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection. MedStar authors:
Year: 2022
Citation: - Jci Insight. 7(5), 2022 03 08.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Aliyu L, Betenbaugh M, Blankson JN, Bloch EM, Broderick P, Caputo CA, Casadevall A, Cox AL, Cramer SM, Dziedzic A, Garliss C, Gebo KA, Gniadek TJ, Hanley D, Hauk P, Heath SL, Jedlicka AE, Klein SL, Koley S, Laeyendecker O, Majewska NI, Mosnaim G, Mostafa HH, Park HS, Patel B, Pekosz A, Rousseau KE, Sachithanandham J, Shapiro JR, Shenoy A, Shoham S, Sitaras I, Spivak ES, Sullivan D, Suwanmanee S, Thakar M, Tobian AA, Woldemeskel BA
|
|
|
66.
|
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies. MedStar authors:
Year: 2013
Citation: - Clinical Cancer Research. 19(13):3681-92, 2013 Jul 1.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Bais C, Brauer MJ, Chen D, Cheng JH, Chung AS, Clermont AC, Ferrara N, Haley B, Hegde P, James CD, Jubb A, Jurinka SS, Kaminker JS, Koeppen H, Kolumam G, Modrusan Z, Ozawa T, Phillips H, Scherer SJ, Schmidt M, Singh M, Stephan JP, Swain SM, Tam RN, Wu X, Yang SX, Yao J, Yeh RF, Yue P, Zhuang G
|
|
|
67.
|
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. MedStar authors:
Year: 2013
Citation: - Journal of the National Cancer Institute. 105(23):1782-8, 2013 Dec 4.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Bandos H, Blackmon NL, Bohn OL, Burandt E, Costantino JP, Fehrenbacher L, Fumagalli D, Gavin PG, Geyer CE Jr, Goldstein LC, Horne ZD, Jeong JH, Kim C, Kim SI, Kim SR, Lee A, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Reilly ML, Remillard MY, Romond EH, Sneige N, Swain SM, Tanaka N, Taniyama Y, Wickerham DL, Wolmark N
|
|
|
68.
|
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study. MedStar authors:
- Alsaadi, Dana
- Charabaty, Aline
- Jennings, Joseph
Year: 2018
Citation: - Journal for Immunotherapy of Cancer. 6(1):142, 2018 Dec 05.
Institution: - MedStar Washington Hospital Center
Department: - Gastroenterology/Hepatology
Medline publication type:
All authors: - Abu-Sbeih H, Ali FS, Alsaadi D, Charabaty A, Gong Z, Jennings J, Luo W, Richards DM, Wang Y
|
|
|
69.
|
Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Oncology. 33(12):1340-7, 2015 Apr 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Blackmon NL, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Kim SR, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
|
|
|
70.
|
Sustained Domestic Vector Exposure Is Associated With Increased Chagas Cardiomyopathy Risk but Decreased Parasitemia and Congenital Transmission Risk Among Young Women in Bolivia. MedStar authors:
Year: 2015
Citation: - Clinical Infectious Diseases. 61(6):918-26, 2015 Sep 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Abastoflor Mdel C, Bern C, Bozo R, Colanzi R, Do RQ, Galdos-Cardenas G, Gilman RH, Jois M, Kaplinski M, LaFuente C, Marcus R, Pena MS, Rendell VR, Shah V, Valencia E, Verastegui M, Working Group on Chagas Disease in Bolivia and Peru
|
|
|
71.
|
|
|
|
72.
|
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. MedStar authors:
Year: 2020
Citation: - Clinical Cancer Research. 26(6):1258-1266, 2020 03 15.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Attia S, Bolejack V, Burgess M, Davis LE, Hu J, Keung EZ, Lazar AJ, Movva S, Okuno S, Parra Cuentas E, Priebat DA, Reed DR, Reinke DK, Reuben A, Riedel RF, Rodrigues-Canales J, Roland CL, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wang WL, Wargo JA
|
|
|
73.
|
|
|
|
74.
|
Advances in Stroke 2017. [Review] MedStar authors:
Year: 2018
Citation: - Stroke. 49(5):e174-e199, 2018 05.
Institution: - MedStar National Rehabilitation Network
Medline publication type:
All authors: - Amin-Hanjani S, Becker KJ, Bennett DA, Bernhardt J, Dichgans M, Ford GA, Goldstein LB, Goyal M, Greenberg SM, Howard G, Keller E, Kidwell CS, Olivot JM, Pantoni L, Pierot L, Planas AM, Reeves M, Saposnik G, Strbian D, Thrift A, Tymianski M, Woo D, Yenari MA, Zorowitz RD
|
|
|
75.
|
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(6):461-71, 2013 May.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
76.
|
Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy. MedStar authors:
Year: 2013
Citation: - Transplantation. 96(7):649-56, 2013 Oct 15.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Alachkar N, Arend LJ, Burke G, Estrella MM, Fornoni A, Jackson AM, Kakkad K, Rabb H, Racusen LC, Reiser J, Wei C
|
|
|
77.
|
Ten-year screening for thrombocytopenia after aortic valve replacement. MedStar authors:
- Chen, Fang
- Corso, Paul J
- Ellis, Jennifer
- Hill, Peter C
- Sun, Xiumei
- Taylor-Panek, Sharon L
Citation: - Interactive Cardiovascular & Thoracic Surgery. 18(5):562-7, 2014 May.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Medline publication type:
All authors: - Chen F, Corso PJ, Ellis J, Hill PC, Sun X, Taylor-Panek SL
|
|
|
78.
|
Intensive care medicine research agenda on invasive fungal infection in critically ill patients. [Review] MedStar authors:
Year: 2017
Citation: - Intensive Care Medicine. 43(9):1225-1238, 2017 Sep.
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
All authors: - Azoulay E, Bassetti M, Calandra T, Chakrabarti A, Cornely OA, Dimopoulos G, Garnacho-Montero J, Kett D, Kullberg B, Leon C, Ostrosky-Zeichner L, Richardson MD, Sanguinetti M, Shorr A, Timsit JF
|
|
|
79.
|
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(12):1183-92, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky AM, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Margolese RG, Paik S, Rastogi P, Robidoux A, Sarwar S, Shibata HR, Swain SM, Tang G, Wolmark N
|
